Seres Therapeutics Inc (MCRB)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -37.414 | -38.679 | -63.835 | -55.576 | -37.497 | -18.796 | -71.103 | -32.153 |
| Return on Equity (%) | -54.185 | -92.464 | -1563.806 | 145.854 | -140.995 | -42.825 | -351.616 | 667.531 |
| Return on Invested Capital (%) | -59.964 | -105.425 | -775.382 | 213.333 | -143.198 | -44.596 | -270.292 | -458.809 |
| Operating Margin (%) | -416.291 | -278.442 | -350.027 | -202.223 | -259.53 | -43.241 | -3425.042 | -79.595 |
| Net Profit Margin (%) | -420.743 | -278.442 | -350.027 | -203.678 | -268.334 | -45.249 | -3509.498 | -90.025 |
| Book Value Per Share | 3.287 | 1.496 | -1.174 | -0.689 | 1.911 | 1.431 | 0.086 | -0.347 |
| Earnings Per Share | -2.269 | -2.203 | -2.417 | -1.002 | -0.975 | -0.714 | -1.998 | -0.88 |
| Cash Per Share | 1.351 | 0.89 | 2.096 | 0.928 | 1.269 | 1.959 | 1.302 | 0.99 |
| Working Capital Per Share | 4.161 | 3.043 | 1.237 | 0.773 | 2.431 | 2.409 | 0.872 | 0.594 |
| Operating Profit Per Share | 0.539 | 0.791 | 0.691 | 0.492 | 0.363 | 1.596 | 0.057 | 0.977 |
| EBIT Per Share | -2.269 | -2.203 | -2.417 | -1.002 | -0.975 | -0.714 | -1.998 | -0.88 |
| EBITDA Per Share | -2.269 | -2.203 | -2.417 | -1.002 | -0.975 | -0.714 | -1.998 | -0.88 |
| Free Cash Flow Per Share | -1.841 | -2.267 | -2.562 | -1.096 | -1.04 | -0.674 | -1.972 | -0.866 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 40.36M | 40.57M | 40.94M | 70.14M | 91.46M | 91.89M | 125.22M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 125.22M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | 13261.686 | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | 13634.866 | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 139.65M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 1.14 |
| Price to Cash Ratio | 1.12 |
| Price to Book Ratio | -3.2 |
| Dividend Yield | - |
| Shares Outstanding | 170.74M |
| Average Volume (1 week) | 885.68k |
| Average Volume (1 Month) | 2.04M |
| 52 Week Change | -26.08% |
| 52 Week High | 1.53 |
| 52 Week Low | 0.54 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
